Stopping Natalizumab May Increase Risk of MS Relapse
The RESTORE trial showed that MRI and clinical MS activity recurred during natalizumab interruption in some patients who had been relapse-free for 1 year
The RESTORE trial showed that MRI and clinical MS activity recurred during natalizumab interruption in some patients who had been relapse-free for 1 year
Despite use of other therapies, magnetic resonance imaging and clinical activity of multiple sclerosis recurred during...
Clinical Research